Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 13 studies | 40% ± 16% | |
macrophage | 11 studies | 25% ± 8% | |
endothelial cell | 11 studies | 23% ± 7% | |
microglial cell | 7 studies | 26% ± 9% | |
fibroblast | 7 studies | 19% ± 4% | |
astrocyte | 7 studies | 32% ± 13% | |
epithelial cell | 6 studies | 32% ± 12% | |
non-classical monocyte | 5 studies | 19% ± 5% | |
endothelial cell of lymphatic vessel | 5 studies | 20% ± 5% | |
oligodendrocyte precursor cell | 5 studies | 34% ± 13% | |
monocyte | 5 studies | 20% ± 1% | |
classical monocyte | 4 studies | 23% ± 5% | |
conventional dendritic cell | 4 studies | 24% ± 7% | |
myeloid cell | 3 studies | 23% ± 3% | |
retinal bipolar neuron | 3 studies | 26% ± 6% | |
ciliated cell | 3 studies | 24% ± 7% | |
rod bipolar cell | 3 studies | 55% ± 11% | |
GABAergic neuron | 3 studies | 42% ± 2% | |
glutamatergic neuron | 3 studies | 50% ± 2% | |
dendritic cell | 3 studies | 29% ± 8% | |
basal cell | 3 studies | 31% ± 7% | |
interneuron | 3 studies | 36% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2806.79 | 1445 / 1445 | 100% | 27.45 | 183 / 183 |
ovary | 100% | 2471.85 | 180 / 180 | 100% | 21.06 | 430 / 430 |
brain | 100% | 2938.40 | 2640 / 2642 | 100% | 32.45 | 705 / 705 |
lung | 100% | 2806.09 | 577 / 578 | 100% | 22.31 | 1154 / 1155 |
breast | 100% | 3136.16 | 459 / 459 | 100% | 32.79 | 1115 / 1118 |
prostate | 100% | 2562.51 | 245 / 245 | 100% | 25.10 | 500 / 502 |
thymus | 100% | 3368.63 | 653 / 653 | 99% | 30.68 | 601 / 605 |
kidney | 100% | 2317.02 | 89 / 89 | 99% | 26.43 | 894 / 901 |
uterus | 100% | 3278.10 | 170 / 170 | 99% | 26.41 | 453 / 459 |
bladder | 100% | 2763.48 | 21 / 21 | 99% | 23.68 | 497 / 504 |
pancreas | 99% | 1654.88 | 326 / 328 | 99% | 24.95 | 176 / 178 |
stomach | 100% | 1975.44 | 359 / 359 | 98% | 25.18 | 280 / 286 |
intestine | 100% | 3153.52 | 966 / 966 | 98% | 25.37 | 514 / 527 |
adrenal gland | 100% | 2458.34 | 258 / 258 | 96% | 13.89 | 220 / 230 |
skin | 100% | 2872.92 | 1809 / 1809 | 93% | 22.64 | 438 / 472 |
liver | 100% | 1243.33 | 226 / 226 | 92% | 13.87 | 374 / 406 |
blood vessel | 100% | 3098.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3091.58 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.22 | 1 / 1 |
adipose | 100% | 2960.44 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1421.92 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1400.07 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 22.11 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 16.74 | 28 / 29 |
peripheral blood | 94% | 2421.30 | 872 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 9.06 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070527 | Biological process | platelet aggregation |
GO_0007269 | Biological process | neurotransmitter secretion |
GO_0032868 | Biological process | response to insulin |
GO_0006886 | Biological process | intracellular protein transport |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0006904 | Biological process | vesicle docking involved in exocytosis |
GO_0045955 | Biological process | negative regulation of calcium ion-dependent exocytosis |
GO_0043312 | Biological process | neutrophil degranulation |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0022615 | Biological process | protein to membrane docking |
GO_0030073 | Biological process | insulin secretion |
GO_0007420 | Biological process | brain development |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0031091 | Cellular component | platelet alpha granule |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0070820 | Cellular component | tertiary granule |
GO_0042581 | Cellular component | specific granule |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0030141 | Cellular component | secretory granule |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0017075 | Molecular function | syntaxin-1 binding |
GO_0005515 | Molecular function | protein binding |
GO_0019905 | Molecular function | syntaxin binding |
Gene name | STXBP3 |
Protein name | Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) |
Synonyms | |
Description | FUNCTION: Together with STX4 and VAMP2, may play a role in insulin-dependent movement of GLUT4 and in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes. . |
Accessions | ENST00000370008.4 O00186 |